Expression profiles of immune-related genes are associated with neoadjuvant ipilimumab clinical benefit

by Ahmad A. Tarhini, Yan Lin, Hui-Min Lin, Priyanka Vallabhaneni, Cindy Sander, William LaFramboise, Lana Hamieh
Published 2017-02-01

High-dose interleukin-2 (HD IL-2) for advanced melanoma: a single center experience from the University of Pittsburgh Cancer Institute

by Diwakar Davar, Fei Ding, Melissa Saul, Cindy Sander, Ahmad A. Tarhini, John M. Kirkwood, Hussein A. Tawbi
Published 2017-09-01

Pro-Inflammatory Cytokines Predict Relapse-Free Survival after One Month of Interferon-α but Not Observation in Intermediate Risk Melanoma Patients.

by Ahmad A Tarhini, Yan Lin, Haris Zahoor, Yongli Shuai, Lisa H Butterfield, Steven Ringquist, Helen Gogas, Cindy Sander, Sandra Lee, Sanjiv S Agarwala, John M Kirwood
Published 2015-01-01

Immune monitoring of the circulation and the tumor microenvironment in patients with regionally advanced melanoma receiving neoadjuvant ipilimumab.

by Ahmad A Tarhini, Howard Edington, Lisa H Butterfield, Yan Lin, Yongli Shuai, Hussein Tawbi, Cindy Sander, Yan Yin, Matthew Holtzman, Jonas Johnson, Uma N M Rao, John M Kirkwood
Published 2014-01-01

Mitochondrial respiration--an important therapeutic target in melanoma.

by Michelle Barbi de Moura, Garret Vincent, Shelley L Fayewicz, Nicholas W Bateman, Brian L Hood, Mai Sun, Joseph Suhan, Stefan Duensing, Yan Yin, Cindy Sander, John M Kirkwood, Dorothea Becker, Thomas P Conrads, Bennett Van Houten, Stergios J Moschos
Published 2012-01-01